Vital KSK Holdings (FRA:4GX) EBIT: €66 Mil (TTM As of Mar. 2026)


FRA:4GX Vital KSK Holdings Inc FRA:4GX
70 GF Score
Price €8.30
GF Value €7.05
! 6 Warning Signs
View Full Analysis

What is Vital KSK Holdings EBIT?

Vital KSK Holdings FRA:4GX 70 EBIT is €66 Mil as of Mar. 2026. GuruFocus rates FRA:4GX with a GF Score™ of 70/100 and a GF Value™ of €7.05. The stock has 6 warning signs investors should review.

Vital KSK Holdings's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €13 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €66 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Vital KSK Holdings's annualized ROC % for the quarter that ended in Mar. 2026 was 1.75%. Vital KSK Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 18.41%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Vital KSK Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 20.12%.


Vital KSK Holdings  (FRA:4GX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Vital KSK Holdings's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=19.82 * ( 1 - 35.48% )/( (721.032 + 744.506)/ 2 )
=12.787864/732.769
=1.75 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1886.408 - 1118.808 - ( 192.047 - max(0, 1187.499 - 1234.067+192.047))
=721.032

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1747.458 - 939.251 - ( 125.12 - max(0, 998.751 - 1062.452+125.12))
=744.506

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Vital KSK Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=51.132/( ( (277.603 + max(-199.978, 0)) + (277.953 + max(-120.788, 0)) )/ 2 )
=51.132/( ( 277.603 + 277.953 )/ 2 )
=51.132/277.778
=18.41 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(753.387 + 197.853 + 20.21) - (1118.808 + 0 + 52.62)
=-199.978

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(660.857 + 181.43 + 25.134) - (939.251 + 0 + 48.958)
=-120.788

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Vital KSK Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=65.779/326.996
=20.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vital KSK Holdings EBIT Related Terms


Vital KSK Holdings EBIT Historical Data

* Premium members only.

The historical data trend for Vital KSK Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vital KSK Holdings EBIT Chart

Vital KSK Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.32 57.35 53.89 66.85 63.07

Vital KSK Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.68 7.93 35.94 9.13 12.78

FRA:4GX vs MCK, CAH, COR: EBIT Comparison

For the Medical Distribution subindustry, Vital KSK Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vital KSK Holdings EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Vital KSK Holdings's EV-to-EBIT falls into.


FRA:4GX
70GF Score
Vital KSK Holdings Inc FRA:4GX
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vital KSK Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €66 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €66 Mil mean?
Vital KSK Holdings (FRA:4GX) has a EBIT of €66 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Vital KSK Holdings.
Is Vital KSK Holdings' EBIT too high?
Vital KSK Holdings' current EBIT is €66 Mil. Overall, Vital KSK Holdings has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' EBIT compare to MCK and CAH?
Vital KSK Holdings' EBIT of €66 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Vital KSK Holdings. Vital KSK Holdings's current EBIT is €66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Vital KSK Holdings (FRA:4GX) has a current EBIT of €66 Mil. The stock's GF Value™ is €7.05, compared to a current price of €8.30 — trading 17.7% above its estimated fair value. The current EBIT is €66 Mil. Vital KSK Holdings' overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Vital KSK Holdings (FRA:4GX), the current EBIT is €66 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vital KSK Holdings (FRA:4GX) Overvalued in 2026?

Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued. The current stock price of €8.30 is trading 17.7% above its estimated GF Value™ of €7.05.

Key valuation signals for FRA:4GX:

  • EBIT: €66 Mil
  • GF Value™: €7.05 vs. price of €8.30 (17.7% above fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the FRA:4GX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vital KSK Holdings Business Description

Other Exchanges 3151:Japan
Address 1-1-12 Tsurumaki, Setagaya-ku, JPN, 154-0016
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
70GF Score

Get the complete analysis for FRA:4GX

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.30
Price
€7.05
GF Value